FindTrial
Sign In

Role of Allium Sativum Q and individualized homoeopathic medicine in adults having Essential Hypertension

Efficacy of Allium Sativum Q versus individualized homoeopathic medicine in Essential Hypertension in adults to manage hypertension using MYMOP 2 score : A non-randomized double arm study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099441
Enrollment
60
Registered
2025-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Allium Sativum: Allium Sativum Homoeopathic mother tincture 10-15 drops as per requirement of patient with follow up every 15 days Control Intervention1: Individualized Homoeopathic Med

Sponsors

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults between 18 to 50 years. 2. Patients diagnosed with essential (primary) hypertension as per JNC 8 or WHO guidelines. 3. Patients who are willing to participate and give informed consent form. 4.Gender : both male and female. 5.Grade 1 Hypertension (SBP 140-159 mm of Hg and DBP 90-99 mm Hg .

Exclusion criteria

Exclusion criteria: 1. Patients with secondary hypertension. 2. Patients with severe hypertension (JNC 8-stage 2) who require immediate allopathic intervention. 3. Patients currently on antihypertensive allopathic medications or any other mode of treatment. 4. Pregnant and lactating woman. 5. Patients with major complications.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Allium sativum Q and individualized homoeopathic medicine in reducing blood pressure and improving MYMOP-2 scores in 12-week periodTimepoint: 3 months—

Secondary

MeasureTime frame
To evaluate the correlation between improvements in MYMOP-2 scores and reductions in systolic and diastolic blood pressure in both treatment groupsTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Mayuri Rathod

Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University

samir.gupta87142@paruluniversity.ac.in7709396584

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026